Product information and disease descriptionPlace of product in therapyDisease descriptionEpidemiology
Prevalence of Tumor hyperinsulinism
7 evidence topics · 5 sources
Benign and malignant insulinoma, Japan, 2017 to 2018: nationwide survey prevalence
“A nationwide, questionnaire‐based survey was carried out to determine the number of patients with EHH who were treated for hypoglycemia or hypoglycemia‐related complications in 2017−2018.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“205 with insulinoma (118 benign, 18 malignant and 69 unknown subtype)” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“The estimated prevalence was 0.16 per 100,000 population.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“insulinoma was more prevalent among female patients than among male patients (140/65), although the sex difference was smaller in those with malignant cases (10/8).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“compared with the pediatric clinics, the response rate from the adult clinics was lower (68.1% vs 38.2%), which might have affected the estimated prevalence of each EHH disorder.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Pancreatic neuroendocrine tumors including insulinoma, Japan, 2010: nationwide survey of treated patients
“Here, we conducted the second nationwide survey on patients with GEP-NETs who received treatment in 2010.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“A total of 3,379 patients received treatment for PNETs in 2010, representing a 1.2-fold increase in the number of patients from 2005 to 2010. The prevalence was estimated to be 2.69/100,000, with an annual onset incidence of 1.27/100,000 in 2010.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Non-functioning tumor (NF)-PNETs comprised 65.5% of cases followed by insulinoma (20.9%) and gastrinoma (8.2%).” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
Non-islet cell tumor hypoglycemia: review estimate of prevalence relative to insulinoma
Gastrointestinal stromal tumor, Japan, 2011 to 2023: hypoglycemia from any cause and NICTH at one institution
“Eight patients out of 195 patients met this criteria (4.1%). The causes of hypoglycemia were diverse, including tumor growth, adverse drug effects, post-operation, liver failure, and unknown” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Hypoglycemia was observed in 4.1% of patients with GISTs (all stages) and 14.2% of patients with unresectable/metastatic GISTs.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“The present study identified 1 case with recurrent hypoglycemia due to NICTH.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote